Literature DB >> 17419804

Fusion of diphtheria toxin and urotensin II produces a neurotoxin selective for cholinergic neurons in the rat mesopontine tegmentum.

S D Clark1, H L Alderson, P Winn, M P Latimer, H-P Nothacker, O Civelli.   

Abstract

Urotensin II is a neuropeptide first isolated from fish and later found in mammals: where it has potent cardiovascular, endocrine and behavioral effects. In rat brain the urotensin II receptor (UII-R) is predominately expressed in the cholinergic neurons of the pedunculopontine (PPTg) and laterodorsal tegmental nuclei. Typically, the function of the PPTg has been examined using excitotoxins, destroying both cholinergic and non-cholinergic neurons, which confounds interpretation. We took advantage of UII-R's unique expression profile, by combining UII with diphtheria toxin, to engineer a toxin specific for cholinergic neurons of the PPTg. In vitro, two different toxin constructs were shown to selectively activate UII-R (average EC50 approximately 30 nmol/L; calcium mobility assay) and to be 10,000-fold more toxic to UII-R expressing CHO cells, than wildtype cells (average LD50 approximately 2 nmol/L; cell viability). In vivo, pressure injection into the PPTg of rats, resulted in specific loss of choline transporter and NADPH diaphorase positive neurons known to express the UII-R. The lesions developed over time, resulting in the loss of over 80% of cholinergic neurons at 21 days, with little damage to surrounding neurons. This is the first highly selective molecular tool for the depletion of mesopontine cholinergic neurons. The toxin will help to functionally dissect the pedunculopontine and laterodorsal tegmental nuclei, and advance the understanding of the functions of these structures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17419804     DOI: 10.1111/j.1471-4159.2007.04529.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.

Authors:  C Karachi; Chantal Francois
Journal:  J Neural Transm (Vienna)       Date:  2017-01-13       Impact factor: 3.575

Review 2.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

3.  Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease.

Authors:  Carine Karachi; David Grabli; Frédéric A Bernard; Dominique Tandé; Nicolas Wattiez; Hayat Belaid; Eric Bardinet; Annick Prigent; Hans-Peter Nothacker; Stéphane Hunot; Andreas Hartmann; Stéphane Lehéricy; Etienne C Hirsch; Chantal François
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

4.  Increased latencies to initiate cocaine self-administration following laterodorsal tegmental nucleus lesions.

Authors:  Stephan Steidl; Katherine M Cardiff; Roy A Wise
Journal:  Behav Brain Res       Date:  2015-03-05       Impact factor: 3.332

5.  Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.

Authors:  Hayat Belaid; Joëlle Adrien; Elodie Laffrat; Dominique Tandé; Carine Karachi; David Grabli; Isabelle Arnulf; Stewart D Clark; Xavier Drouot; Etienne C Hirsch; Chantal François
Journal:  J Neurosci       Date:  2014-07-02       Impact factor: 6.167

6.  Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.

Authors:  David Grabli; Carine Karachi; Emmanuelle Folgoas; Morgane Monfort; Dominique Tande; Stewart Clark; Olivier Civelli; Etienne C Hirsch; Chantal François
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

7.  Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake.

Authors:  Carlos Blanco-Centurion; Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

Review 8.  The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology.

Authors:  U Maskos
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

9.  Enhanced consumption of salient solutions following pedunculopontine tegmental lesions.

Authors:  D A A MacLaren; T Markovic; D Daniels; S D Clark
Journal:  Neuroscience       Date:  2014-10-08       Impact factor: 3.590

10.  Microinjection of urotensin II into the pedunculopontine tegmentum leads to an increase in the consumption of sweet tastants.

Authors:  Robert Ettaro; Tamara Markovic; Derek Daniels; Duncan Aa MacLaren; Stewart D Clark
Journal:  Physiol Behav       Date:  2019-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.